Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription


3 Am Heart J
18 Am J Cardiol
1 Am J Emerg Med
1 Ann Thorac Surg
2 Atherosclerosis
1 Circ Heart Fail
1 Circ Res
4 Circulation
1 Clin Cardiol
1 Curr Opin Cardiol
3 Eur Heart J
2 Heart
9 Int J Cardiol
3 J Am Coll Cardiol
6 J Cardiovasc Pharmacol
1 J Electrocardiol
1 J Mol Cell Cardiol
1 J Thorac Cardiovasc Surg
2 Mayo Clin Proc
2 PLoS One
1 Prog Cardiovasc Dis

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. ICHIKAWA K, Hansen S, Manubolu VS, Pourafkari L, et al
    Prognostic value of Coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the Multi-Ethnic Study of Atherosclerosis.
    Am Heart J. 2023 Jul 28:S0002-8703(23)00180-1. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available

  2. VAN DER SANGEN NMR, Kucuk IT, Sivanesan S, Appelman Y, et al
    Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients: Rationale and Design of the LEGACY study.
    Am Heart J. 2023 Jul 28:S0002-8703(23)00183-7. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available

  3. WILLIAMS BA, Rajpura J, Paprocki YM, Kumar N, et al
    Temporal Trends in Cardiovascular Outcomes and Costs Among Patients with Type 2 Diabetes.
    Am Heart J. 2023 Jul 27:S0002-8703(23)00185-0. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available

    Am J Cardiol

  4. PARK C, Yoo K, Lee S, Kim H, et al
    The Prognostic Significance of Leukocyte Count on All-Cause and Cardiovascular Disease Mortality: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2023;203:226-233.
    PubMed         Abstract available

  5. SUH EH, Probst MA, Tichter AM, Ranard LS, et al
    Flexible-Interval High-Sensitivity Troponin Velocity for the Detection of Acute Coronary Syndromes.
    Am J Cardiol. 2023;203:240-247.
    PubMed         Abstract available

  6. AFIFY H, Gonzalez-Morales U, Asmar A, Alvarez CA, et al
    Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins.
    Am J Cardiol. 2023;203:274-284.
    PubMed         Abstract available

  7. DESAI SR, Dhindsa DS, Ko YA, Sandesara PB, et al
    Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery Disease.
    Am J Cardiol. 2023;203:315-324.
    PubMed         Abstract available

  8. MURAI K, Fujino M, Iwai T, Sawada K, et al
    Distal Radial Approach in Coronary Angiography Using a Transdermal Nitroglycerin Patch: Double-Blinded Randomized Trial.
    Am J Cardiol. 2023;203:325-331.
    PubMed         Abstract available

  9. PARK HW, Jo S, Park KS, Lee H, et al
    Differential Impact of Degree of Hypertension on Subclinical Coronary Atherosclerosis in Asymptomatic Subjects With and Without Diabetes Mellitus.
    Am J Cardiol. 2023;203:343-351.
    PubMed         Abstract available

  10. SHIBAHASHI E, Abe T, Kamishima K, Ebihara S, et al
    Direct Oral Anticoagulants Affect Activated Clotting Time During and Bleeding Events After Percutaneous Coronary Intervention.
    Am J Cardiol. 2023;204:1-8.
    PubMed         Abstract available

  11. LAUKKANEN JA, Kunutsor SK
    Is Improving Educational Attainment Key to Reducing the Burden Because of Cardiovascular Diseases?
    Am J Cardiol. 2023 Jul 31:S0002-9149(23)00582.

  12. SHAH B, Smilowitz NR, Xia Y, Feit F, et al
    Major Adverse Cardiovascular Events After Colchicine Administration Before Percutaneous Coronary Intervention: Follow-Up of the Colchicine-PCI Trial.
    Am J Cardiol. 2023;204:26-28.
    PubMed         Abstract available

  13. PARK JI, Lee SJ, Hong YJ, Yoo SY, et al
    Efficacy of Percutaneous Coronary Intervention With Synergy Stents in Patients Aged >/=75 Years: 1-Year Clinical Outcomes from the Synergy Elderly Registry.
    Am J Cardiol. 2023;204:43-52.
    PubMed         Abstract available

  14. AROW Z, Gabarin M, Abu-Hosein H, Giladi E, et al
    Eyeball Test for the Assessment of Frailty in Elderly Patients With Cardiovascular Disease: A Prospective Study.
    Am J Cardiol. 2023;204:9-13.
    PubMed         Abstract available

  15. ZAHALKA M, Sanchez-Jimenez E, Levi Y, Abu-Fanne R, et al
    Clinical Use of CathPCI Registry Risk Score and Its Validation to Predict Long-Term Mortality.
    Am J Cardiol. 2023;201:268-272.
    PubMed         Abstract available

  16. BECKER MAJ, van der Lingen ACJ, Cornel JH, van de Ven PM, et al
    Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis.
    Am J Cardiol. 2023;201:294-301.
    PubMed         Abstract available

  17. EKMEJIAN A, Brieger D, Bhat A, Sritharan H, et al
    Vessel-Specific Outcomes of Deferred Revascularization Following Negative Fractional Flow Reserve.
    Am J Cardiol. 2023;201:320-327.
    PubMed         Abstract available

  18. CHAN B, Buckley T, Tofler GH
    Emotional Stress and Physical Exertion as Triggers of Acute Myocardial Infarction.
    Am J Cardiol. 2023;203:285-287.

  19. AWAN RU, Iyer A, Khan UA, Majeed H, et al
    Insights Into Clinical Outcomes of Acute Pancreatitis With Concomitant Acute Myocardial Infarction Using the National Inpatient Sample Database.
    Am J Cardiol. 2023;203:295-300.
    PubMed         Abstract available

  20. ISMAYL M, Hussain Y, Aboeata A, Walters RW, et al
    Pulmonary Artery Catheter Use and Outcomes in Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock Treated With Impella (a Nationwide Analysis from the United States).
    Am J Cardiol. 2023;203:304-314.
    PubMed         Abstract available

  21. OBAYASHI Y, Shiomi H, Morimoto T, Miyake M, et al
    The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2023;203:384-393.
    PubMed         Abstract available

    Am J Emerg Med

    Aspects of the association of ST elevation myocardial infarction and diabetic ketoacidosis.
    Am J Emerg Med. 2023 Jul 23:S0735-6757(23)00399.

    Ann Thorac Surg

  23. BAKAEEN FG, Ruel M, Calhoon JH, Girardi LN, et al
    STS/AATS-Endorsed Rebuttal to 2023 ACC/AHA Chronic Coronary Disease Guideline: A Missed Opportunity to Present Accurate and Comprehensive Revascularization Recommendations.
    Ann Thorac Surg. 2023 Jul 25:S0003-4975(23)00132.


  24. LI Z, Lin C, Cai X, Hu S, et al
    Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
    Atherosclerosis. 2023;379:117181.
    PubMed         Abstract available

  25. ADAY AW, Bagheri M, Vaitinadin NS, Mosley JD, et al
    Polygenic risk score in comparison with C-reactive protein for predicting incident coronary heart disease.
    Atherosclerosis. 2023;379:117194.
    PubMed         Abstract available


  26. SATTAR N
    There is no evidence that vitamin D prevents cardiovascular events.
    BMJ. 2023;382:p1765.

    Study results show vitamin D is around 99% ineffective in preventing major cardiovascular events.
    BMJ. 2023;382:p1767.

    Circ Heart Fail

  28. FURUSAWA S, Ikeda M, Ide T, Kanamura T, et al
    Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics.
    Circ Heart Fail. 2023 Jul 31:e010347. doi: 10.1161/CIRCHEARTFAILURE.122.010347.
    PubMed         Abstract available

    Circ Res

  29. WIDLANSKY ME, Liu Y, Tumusiime S, Hofeld B, et al
    Coronary Plaque Sampling Reveals Molecular Insights Into Coronary Artery Disease.
    Circ Res. 2023 Aug 4. doi: 10.1161/CIRCRESAHA.123.323022.


    Letter by Cainzos-Achirica Regarding Article, "Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)".
    Circulation. 2023;148:440.

  31. SANDHU AT, Rodriguez F, Maron DJ
    Response by Sandhu et al to Letter Regarding Article, "Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)".
    Circulation. 2023;148:441.

  32. GAUDINO M, Dangas GD, Angiolillo DJ, Brodt J, et al
    Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Jun 22. doi: 10.1161/CIR.0000000000001154.
    PubMed         Abstract available

  33. YU CK, Tsao S, Ng CW, Chua GT, et al
    Cardiovascular Assessment up to One Year After COVID-19 Vaccine-Associated Myocarditis.
    Circulation. 2023;148:436-439.

    Clin Cardiol

  34. LI Y, Zhang Y, Xiao K, Si J, et al
    The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk.
    Clin Cardiol. 2023 Jul 31. doi: 10.1002/clc.24087.
    PubMed         Abstract available

    Curr Opin Cardiol

  35. PARFREY S, Siu V, Graham JJ, Vijayaraghavan R, et al
    Evaluation and management of drug-eluting stent in-stent restenosis.
    Curr Opin Cardiol. 2023;38:433-440.
    PubMed         Abstract available

    Eur Heart J

  36. LIUZZO G, Patrono C
    Acute myocardial infarction is associated with faster age-related cognitive decline.
    Eur Heart J. 2023 Aug 1:ehad475. doi: 10.1093.

  37. VERGALLO R, Patrono C
    Machine learning and myocardial infarction diagnosis: sometimes you can't make it on your own.
    Eur Heart J. 2023 Aug 1:ehad467. doi: 10.1093.

  38. SANCHEZ-CABO F, Fuster V, Silla-Castro JC, Gonzalez G, et al
    Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.
    Eur Heart J. 2023;44:2698-2709.
    PubMed         Abstract available


  39. MCCABE JM, Chung CJ
    Surgical and transcatheter treatments of mechanical complications of acute myocardial infarction.
    Heart. 2023 Jul 31:heartjnl-2022-321573. doi: 10.1136/heartjnl-2022-321573.

  40. RASMUSSEN LD, Winther S, Karim SR, Westra J, et al
    Likelihood reclassification by an acoustic-based score in suspected coronary artery disease.
    Heart. 2023;109:1223-1230.
    PubMed         Abstract available

    Int J Cardiol

  41. DAKSHI A, Salmon T, Collinson P, Ihsan J, et al
    Unstable angina in the context of high-sensitive troponins: Still a marker of high risk? A comparison of outcomes with adjudicated type 1 myocardial infarction.
    Int J Cardiol. 2023 Jul 29:131226. doi: 10.1016/j.ijcard.2023.131226.
    PubMed         Abstract available

  42. DE KONING MLY, Al Ali L, Bourgonje AR, Assa S, et al
    Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jul 28:131214. doi: 10.1016/j.ijcard.2023.131214.
    PubMed         Abstract available

  43. YAMAMOTO T, Kawamori H, Toba T, Kakizaki S, et al
    Clinical impact of optical coherence tomography findings after drug-coated balloon treatment for patients with acute coronary syndromes.
    Int J Cardiol. 2023;387:131149.
    PubMed         Abstract available

  44. CHONG TK, Chen J, Lyu L, Wei Y, et al
    Clinical characteristics and outcome correlates of Chinese patients with takotsubo syndrome: Results from the first Chinese takotsubo syndrome registry.
    Int J Cardiol. 2023;387:131129.
    PubMed         Abstract available

  45. MITSUTAKE Y, Ishii J, Fukumoto Y, Ito S, et al
    Differential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery disease.
    Int J Cardiol. 2023;387:131138.
    PubMed         Abstract available

  46. ROZADO J, Avanzas P
    Complete revascularization in STEMI and multivessel coronary artery disease: In search of the best strategy.
    Int J Cardiol. 2023;387:131124.

  47. WU H, Xiao Z
    A knowledge graph-based analytical model for mining clinical value of drug stress echocardiography for diagnosis, risk stratification and prognostic evaluation of coronary artery disease.
    Int J Cardiol. 2023;387:131107.
    PubMed         Abstract available

  48. SHARIFOV OF, Denney TS Jr, Girard AA, Gupta H, et al
    Coronary artery disease is associated with impaired atrial function regardless of left ventricular filling pressure.
    Int J Cardiol. 2023;387:131102.
    PubMed         Abstract available

  49. XU C, Meng J, He J
    History of peripheral artery disease as a cardiovascular risk predictor of patients with acute coronary syndrome.
    Int J Cardiol. 2023;387:131105.

    J Am Coll Cardiol

  50. SANDOVAL Y, Jaffe AS
    The Evolving Role of Cardiac Troponin: From Acute to Chronic Coronary Syndromes.
    J Am Coll Cardiol. 2023;82:486-488.

  51. WERESKI R, Adamson P, Shek Daud NS, McDermott M, et al
    High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:473-485.
    PubMed         Abstract available

  52. DEHMER GJ, Grines CL, Bakaeen FG, Beasley DL, et al
    2023 AHA/ACC Clinical Performance and Quality Measures for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
    J Am Coll Cardiol. 2023 Jul 21:S0735-1097(23)05187.

    J Cardiovasc Pharmacol

  53. CHEN R, Zhang Y, Zhou H, Hu Y, et al
    SGLT2 inhibitor-pretreated macrophage transplantation improves adverse ventricular remodeling after acute myocardial infarction.
    J Cardiovasc Pharmacol. 2023 Aug 3. doi: 10.1097/FJC.0000000000001466.
    PubMed         Abstract available

  54. LI Y, Zhang J, He J, Chen X, et al
    Association of the L3MBTL3 rs1125970 and rs4897367 gene polymorphisms with coronary heart disease susceptibility in the Chinese population: a case-control study.
    J Cardiovasc Pharmacol. 2023 Jul 31. doi: 10.1097/FJC.0000000000001464.
    PubMed         Abstract available

  55. MORONI F, Abbate A
    Anti-inflammatory (colchicine) treatment for secondary prevention in coronary artery disease: a milestone has been met.
    J Cardiovasc Pharmacol. 2023 Aug 3. doi: 10.1097/FJC.0000000000001467.

  56. TIAN MY, Wang XY, Chen F, Guo YF, et al
    Comparison of Ticagrelor Monotherapy and Ticagrelor plus Aspirin Among Patients with Acute Coronary Syndrome Combined with High-Risk of Gastrointestinal Bleeding after PCI: a Retrospective Cohort Study.
    J Cardiovasc Pharmacol. 2023 Aug 1. doi: 10.1097/FJC.0000000000001461.
    PubMed         Abstract available

  57. BORGI M, Peruzzi M, Biondi-Zoccai G, Versaci F, et al
    Trimetazidine after coronary revascularization: much ado about nothing?
    J Cardiovasc Pharmacol. 2023 Aug 1. doi: 10.1097/FJC.0000000000001462.

  58. ALGAIDI SH, Alghamdi DI, Algheffari SG, Alzahrani RA, et al
    Long-term cardiovascular adverse events induced by fluoroquinolones: A retrospective case-control study.
    J Cardiovasc Pharmacol. 2023 Aug 1. doi: 10.1097/FJC.0000000000001459.
    PubMed         Abstract available

    J Electrocardiol

    Common ECG interpretation software mistakes. Part I: False reporting of myocardial infarction.
    J Electrocardiol. 2023;81:32-35.
    PubMed         Abstract available

    J Mol Cell Cardiol

  60. DYKES IM, van Bueren KL, Scambler PJ
    Corrigendum to "HIC2 regulates isoform switching during maturation of the cardiovascular system" [Journal of Molecular and Cellular Cardiology volume 114 (2018) P29-37/ https://doi.org/10.1016/j.yjmcc.2017.10.007].
    J Mol Cell Cardiol. 2023 Jul 28:S0022-2828(23)00125.

    J Thorac Cardiovasc Surg

  61. BAKAEEN FG, Ruel M, Calhoon JH, Girardi LN, et al
    STS/AATS-endorsed rebuttal to 2023 ACC/AHA Chronic Coronary Disease Guideline: A missed opportunity to present accurate and comprehensive revascularization recommendations.
    J Thorac Cardiovasc Surg. 2023 Jul 25:S0022-5223(23)00188.


  62. KAWADA T
    Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin.
    JAMA. 2023;330:470-471.

  63. HONG SJ, Lee YJ, Hong MK
    Treating Coronary Artery Disease With Treat-to-Target or High-Intensity Statin-Reply.
    JAMA. 2023;330:471.

    Mayo Clin Proc

  64. SINGH M, El Sabbagh A, Lewis BR, Kanwar A, et al
    Clinical Significance of Biological Age in Patients Undergoing Percutaneous Coronary Intervention.
    Mayo Clin Proc. 2023;98:1137-1152.
    PubMed         Abstract available

    Age or Functional Debility to Predict Death After Percutaneous Coronary Intervention: Age Is More Than a Number.
    Mayo Clin Proc. 2023;98:1110-1112.

    PLoS One

  66. NGAMDU KS, Ghosalkar DS, Chung HE, Christensen JL, et al
    Long-term statin therapy is associated with severe coronary artery calcification.
    PLoS One. 2023;18:e0289111.
    PubMed         Abstract available

  67. CHO YJ, Hyeon C, Nam K, Lee S, et al
    Effects of low versus high inspired oxygen fraction on myocardial injury after transcatheter aortic valve implantation: A randomized clinical trial.
    PLoS One. 2023;18:e0281232.
    PubMed         Abstract available

    Prog Cardiovasc Dis

  68. KRITTANAWONG C, Isath A, Kaplin S, Virk HUH, et al
    Cardiovascular disease in space: A systematic review.
    Prog Cardiovasc Dis. 2023 Jul 31:S0033-0620(23)00075.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.